Curatis Holding AG (XSWX:CURN) Revenue: CHF10.80 Mil (TTM As of Dec. 2025)


XSWX:CURN Curatis Holding AG XSWX:CURN
31 GF Score
Price CHF23.90
! 7 Warning Signs
View Full Analysis

What is Curatis Holding AG Revenue?

Curatis Holding AG XSWX:CURN +1.27% 31 Revenue is CHF10.80 Mil as of Dec. 2025. GuruFocus rates XSWX:CURN with a GF Score™ of 31/100. The stock has 7 warning signs investors should review.

Curatis Holding AG's revenue for the six months ended in Dec. 2025 was CHF5.56 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was CHF10.80 Mil. Curatis Holding AG's Revenue per Share for the six months ended in Dec. 2025 was CHF1.11. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was CHF2.17.

Warning Sign:

Curatis Holding AG revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Curatis Holding AG was -8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Curatis Holding AG  (XSWX:CURN) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Curatis Holding AG Revenue Related Terms


Curatis Holding AG Revenue Historical Data

* Premium members only.

The historical data trend for Curatis Holding AG's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curatis Holding AG Revenue Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
0.00 0.00 0.00 6.90 10.80

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.98 4.92 5.24 5.56

XSWX:CURN vs ZTS, UTHR, VTRS: Revenue Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG Revenue vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Revenue distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Revenue falls into.


XSWX:CURN
31GF Score
Curatis Holding AG XSWX:CURN
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curatis Holding AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF10.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of CHF10.80 Mil mean?
Curatis Holding AG (XSWX:CURN) has a Revenue of CHF10.80 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Curatis Holding AG and its competitors.
Is Curatis Holding AG's Revenue too high?
Curatis Holding AG's current Revenue is CHF10.80 Mil. Overall, Curatis Holding AG has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Curatis Holding AG's Revenue compare to ZTS and UTHR?
Curatis Holding AG's Revenue of CHF10.80 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Drug Manufacturers company?
A good Revenue depends on the Drug Manufacturers industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Curatis Holding AG and its competitors. Curatis Holding AG's current Revenue is CHF10.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curatis Holding AG stock overvalued right now?
Curatis Holding AG (XSWX:CURN) has a current Revenue of CHF10.80 Mil. The current Revenue is CHF10.80 Mil. Curatis Holding AG's overall GF Score™ is 31/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Curatis Holding AG (XSWX:CURN), the current Revenue is CHF10.80 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curatis Holding AG Business Description

Other Exchanges CURNz:UK0QNS:UK26U:Germany
Address Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical Company with two-pillar. On one hand, the Company trades and distributes specialty medicines in the rare disease and specialty medicines space i.e. acquires, licenses, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and specialty diseases in Switzerland. On the other hand, it is a drug development Company with a pipeline of product candidates, also predominantly in the orphan drug space.
31GF Score

Get the complete analysis for XSWX:CURN

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF23.90
Price